Adam Koppel - Insider Trading & Ownership

Entity
Individual
Location
C/O Brookside Capital, Llc, John Hancock Tower, 200 Clarendon St, Boston, Massachusetts
Summary
The estimated net worth of Adam Koppel is at least $2.8B dollars as of January 12, 2024. Adam Koppel is the Director, More than 10% owner of Cerevel Therapeutics Holdings, Inc. and owns shares of Cerevel Therapeutics Holdings, Inc. (CERE) worth about $2.77B. Adam Koppel is the Director, More than 10% owner of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) worth about $22.3M. Adam Koppel is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) worth about $49K.
All Insider Reports
All Insider Reports

Ownership of Adam Koppel

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CERE Cerevel Therapeutics Holdings, Inc. Director, More than 10% owner $2.77B +$125M +4.72% Oct 16, 2023
SLDB Solid Biosciences Inc. Director, More than 10% owner $22.3M Jan 11, 2024
FHTX Foghorn Therapeutics Inc. Director $49K Jun 21, 2023
APTX Aptinyx Inc. Director, More than 10% owner May 26, 2022
Dicerna Pharmaceuticals Inc Director Dec 28, 2021

Insider Transactions Reported by Adam Koppel:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership